This report focuses on the global Netupitant-Palonosetron FDC status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Netupitant-Palonosetron FDC development in United States, Europe and China. The netupitant-palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors. Netupitant in the central nervous system inhibits the binding of endogenous tachykinin neuropeptide substance, which prevents chemotherapy-induced nausea and vomiting (CINV). Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy. North America was the dominant regional market for netupitant?palonosetron FDC drugs, in terms of revenue, due to growth in incidence of CINV among patients. In 2017, the global Netupitant-Palonosetron FDC market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Eisai Pharmaceutical Helsinn Heron Therapeutics Tesaro Acacia Pharma ... Market segment by Type, the product can be split into Flakes Capsules Other Market segment by Application, split into Hospital Pharmacy Drug Stores Retail Pharmacy Online Pharmacy Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Netupitant-Palonosetron FDC status, future forecast, growth opportunity, key market and key players. To present the Netupitant-Palonosetron FDC development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Netupitant-Palonosetron FDC are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Netupitant-Palonosetron FDC Market Size Growth Rate by Type (2013-2025) 1.4.2 Flakes 1.4.3 Capsules 1.4.4 Other 1.5 Market by Application 1.5.1 Global Netupitant-Palonosetron FDC Market Shar
